Michael Sweeney
Net worth: 10 406 $ as of 30/06/2026
Net worth: 10 406 $ as of 30/06/2026
Dr. Michael T.
Sweeney, MD, is a Senior Vice President-Clinical Development at Resverlogix Corp.
Dr. Sweeney was previously employed as a Chief Medical Officer, VP-Research & Development by Depomed, Inc., a Vice President-Medical Affairs by CV Therapeutics, Inc., a Senior Director-Urology Global Medial Group Leader by Pfizer Inc., and a Senior Clinical Pharmacologist by Zeneca Group Plc.
He received his doctorate degree from The University of Liverpool.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RESVERLOGIX CORP. 0.05% | 02/04/2025 | 155,312 ( 0.05% ) | 10 406 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| RESVERLOGIX CORP. | Chief Tech/Sci/R&D Officer | 03/11/2014 |
| Companies | Position | End |
|---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/01/2014 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Chief Tech/Sci/R&D Officer | 01/09/2007 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2003 |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions